Early vs. Late Recombinant Human Erythropoietin (rHuEPO) in Anemia of Prematurity: Results of a Randomized, Placebo-Controlled, Multicentric Trial • 1383 | Zendy

AI Assistant Blog Pricing

Early vs. Late Recombinant Human Erythropoietin (rHuEPO) in Anemia of Prematurity: Results of a Randomized, Placebo-Controlled, Multicentric Trial • 1383

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.